Tafinlar (dabrafenib)

pCPA File Number: 20786
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Melanoma
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
pCODR 10025
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: